Operating Lease, Right-of-Use Asset of Jade Biosciences, Inc. from 30 Sep 2021 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Jade Biosciences, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 30 Sep 2021 to 31 Dec 2025.
  • Jade Biosciences, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $726,000.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Jade Biosciences, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $726,000 +$726,000 31 Dec 2025 10-K 06 Mar 2026 2025 FY
Q3 2025 $740,000 +$481,000 +186% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 $777,000 +$156,000 +25% 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 $158,000 -$567,000 -78% 31 Mar 2025 10-Q 25 Apr 2025 2025 Q1
Q4 2024 $0 -$614,000 -100% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 $259,000 -$454,000 -64% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $621,000 -$190,000 -23% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 $725,000 -$183,000 -20% 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q4 2023 $614,000 -$389,000 -39% 31 Dec 2023 10-K 27 Mar 2025 2024 FY
Q3 2023 $713,000 -$381,000 -35% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $811,000 -$377,000 -32% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $908,000 +$409,000 +82% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $1,003,000 +$461,000 +85% 31 Dec 2022 10-K 25 Mar 2024 2023 FY
Q3 2022 $1,094,000 +$511,000 +88% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $1,188,000 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 $499,000 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 $542,000 31 Dec 2021 10-K 29 Mar 2023 2022 FY
Q3 2021 $583,000 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.